Trial
NCT02216513
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
Dr. Jeffrey Thomas Stroke Shield Foundation
Condition
Subarachnoid Hemorrhage
Intervention
desferrioxamine (DFO)
Why stopped
Principle Investigator is moving to another institution and plans to restart this proctocol in the new location.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-21